Nomenclature
CAS number: 55-63-0
1,2,3-Propanetriol trinitrate; glyceryl trinitrate; glycerol nitric acid triester; nitroglycerol; trinitroglycerol; glonoin; trinitrin; blasting gelatin; blasting oil; S.N.G.; Adesitrin (Pharmacia); Anginine (Sigma); Aquo-Trinitrosan (Merck KGaA); Cordipatch (Schwarz); Corditrine (Aventis); Deponit (Schwarz); Diafusor (Fabre); Discotrine (3M Pharma); Lenitral (Besins-Iscovesco); Millisrol (Nippon Kayaku); Minitran (3M Pharma); Nitradisc (Pfizer); Nitro-Bid (Altana); Nitrocine (Schwarz); Nitrocontin (Mundipharma); Nitroderm (Novartis); Nitro-Dur (Schering-Plough); Nitrogard (Forest); Nitroglin (Stada); Nitroglyn (Bradley); Nitrolingual (Pohl); Nitromex (Alpharma); Nitronal (Merck KGaA); Nitrong (Lavipharm); Nitrostat (Warner-Lambert); Nitrosylon (Abbott); Percutol (Pliva); Perlinganit (Schwarz); Rectogesic (Strakan); Suscard (Forest); Sustac (Forest); Transderm-Nitro (Novartis); Transiderm-Nitro (Novartis); Tridil (BMS); Trinitrosan (Merck KGaA).
C
3H
5N
3O
9; mol wt 227.09.
C 15.87%, H 2.22%, N 18.50%, O 63.41%.
Description and references
Nitric oxide donor that induces vasodilation.
Prepn: Sobrero, Ann. 64, 398 (1847); Williamson, Ann. 92, 305 (1854). Review of the early literature: J.
W. Lawrie, Glycerol and the Glycols (New York, 1928). Review of chemistry and biochemistry: F. J.
DiCarlo, Drug Metab. Rev. 4, 1-38 (1975). Review of mechanism of action: S. F. Vatner,
G. R. Heyndrickx, Handb. Exp. Pharmakol. 40, 131-161 (1975). Molecular mechanism of nitric oxide
release: Z. Chen et al., Proc.
Natl. Acad. Sci. USA 99, 8306 (2002). Review
of the first hundred years: J. R. Parratt, J. Pharm. Pharmacol. 31, 801-809 (1979).
Comprehensive description: E. F. McNiff et al., Anal. Profiles Drug Subs. 9, 519-541
(1980). Symposium on nitroglycerin therapy, perspectives and mechanisms:
Am. J. Med. 74, no.
6B, 1-94 (1983). Review of pharmacology and clinical studies of intravenous
administration in heart disease: E. M. Sorkin et al., Drugs 27, 45 (1984). Clinical
trial in treatment of anal fissures: J. H. Scholefield et al., Gut 52, 264 (2005).
Properties
Pale yellow, oily liquid. Sweet burning taste.
Produces headache on tasting. Explosive;
poisonous. Crystallizes in 2 forms: labile form, mp 2.8°; stable form, mp 13.5°. d1515 1.599; d44 1.6144; d415 1.6009; d425 1.5918. nD15 1.474.
Begins to dec at 50-60°, appreciably volatile at 100°, evolves nitrous
yellow vapors at 135°, explodes at 218°. Vapor pressure at 20°:
0.00026 mm; at 93°: 0.31 mm. One gram dissolves in 800 ml water,
in 4 g ethanol, in 18 g methanol, in 120 g carbon disulfide. Misc
with ether, acetone, glacial acetic acid, ethyl acetate, benzene,
nitrobenzene, pyridine, chloroform, ethylene bromide, dichloroethylene.
Sparingly sol in petr ether, liquid petrolatum, glycerol. Heat of
combustion: 1580 cal/g. Explodes on rapid heating or on concussion.
On explosion harmless gases are produced: 4C3H5(ONO2)3 → 12CO2 + 10H2O + 6N2 + O2.Derivative
Spirit of Glyceryl Trinitrate.
Nomenclature
Spirit of nitroglycerin; spirit of glonoin. Description and references
An alcoholic soln contg 1.0-1.1% glyceryl
trinitrate.
Properties
Colorless, clear liquid. d 0.814-0.820. Miscible with alcohol, chloroform,
ether; 1 ml dissolves in 6 ml almond oil; very slightly sol in water;
miscible with chloroform, ether.Caution
Potential symptoms of overexposure
by percutaneous or respiratory absorption are throbbing headache,
dizziness, nausea, vomiting, abdominal pain; hypotension; flushing;
palpitations; methemoglobinemia; delerium, CNS depression; angina;
cyanosis; coma. Direct contact may cause skin irritation. See NIOSH Pocket Guide to Chemical Hazards (DHHS/NIOSH 97-140, 1997) p 228; Patty's
Industrial Hygiene and Toxicology vol. 2B, G.
D. Clayton, F. E. Clayton, Eds. (Wiley-Interscience, New York, 4th
ed., 1994) pp 1064-1067.Use
Manuf of
dynamite (75% nitroglycerol, 24.5% diatomaceous earth, 0.5% sodium
carbonate), smokeless powders and blasting gelatin; in rocket propellants.
Therapeutic Category
Antianginal; vasodilator (coronary). Topically in treatment
of anal fissures.
Therapeutic Category (Veterinary)
Topical vasodilator (coronary); antianginal.
Keywords
Antianginal; Vasodilator (Coronary)